Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52687#.VKC_4cCAM4 Author(s) Tarek Debs , Isabella Reccia * , Imad El-Hajj , Ziad El-Rassi Affiliation(s) Division of General and Visceral Surgery, Saint George Hospital University Medical Centre, Beirut, Lebanon . ABSTRACT Cholangiocarcinoma is an uncommon malignancy that increases with age. Cholangiocarcinoma has been linked to inflammatory bowel disease, and a relationship between inflammatory bowel disease, anti-tumour necrosis factor alpha antibody (Infliximab) and cholangiocarcinoma has been suggested. Although cholangiocarcinoma is usually associated with ulcerative colitis, recently more cases are being seen in a...
Scientific Research Publishing